EQB Inc. (TSX:EQB)

Verve Therapeutics Income Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	2,870	2,965	2,725	1,558	1,083	1,093
Interest Income on Investments	161.73	174.85	162.58	58.23	23.98	28.88
Total Interest Income	3,031	3,140	2,888	1,616	1,107	1,122
Interest Paid on Deposits	1,431	1,490	1,293	579	307.68	364.05
Interest Paid on Borrowings	538.96	598.98	588.74	303.83	217.03	260.21
Total Interest Expense	1,970	2,089	1,882	882.83	524.71	624.26
Net Interest Income	1,062	1,050	1,006	733.41	582.61	497.41
Net Interest Income Growth (YoY)	18.34%	4.43%	37.16%	25.88%	17.13%	7.51%
Other Non-Interest Income	89.54	81.09	56.27	31.08	22.16	22.59
Total Non-Interest Income	217.01	204.95	164.86	48.78	60.3	59.43
Non-Interest Income Growth (YoY)	90.79%	24.32%	237.96%	-19.10%	1.47%	72.67%
Revenues Before Loan Losses	1,279	1,255	1,171	782.19	642.91	556.83
Provision for Loan Losses	118.17	107.01	46.63	37.26	-7.67	42.28
Revenue	1,160	1,148	1,124	744.93	650.58	514.55
Revenue Growth (YoY)	20.96%	2.16%	50.91%	14.50%	26.44%	6.22%
Salaries and Employee Benefits	273.41	256.29	227.11	173.36	122.19	100.66
Selling, General & Administrative	40.88	32.91	25.74	25.38	22.46	18.42
Other Non-Interest Expense	310.35	304.9	268.84	177.73	115.53	94.99
Total Non-Interest Expense	624.64	594.1	521.69	376.47	260.18	214.06
EBT Excluding Unusual Items	535.78	554.33	602.48	368.46	390.41	300.49
Pretax Income	535.78	554.33	602.48	368.46	390.41	300.49
Income Tax Expense	146.21	152.66	156.57	98.28	97.88	76.69
Earnings From Continuing Operations	389.58	401.67	445.91	270.18	292.53	223.8
Minority Interest in Earnings	-1.29	-1.11	-	-	-	-
Net Income	388.29	400.56	445.91	270.18	292.53	223.8
Preferred Dividends & Other Adjustments	10.43	10.73	8.4	5.57	4.41	4.48
Net Income to Common	377.86	389.84	437.51	264.62	288.12	219.33
Net Income Growth	9.74%	-10.17%	65.04%	-7.64%	30.71%	8.39%
Basic Shares Outstanding	38	38	38	35	34	34
Diluted Shares Outstanding	39	39	38	35	34	34
Shares Change (YoY)	5.30%	1.41%	8.51%	1.70%	1.65%	0.51%
EPS (Basic)	9.84	10.19	11.60	7.63	8.49	6.52
EPS (Diluted)	9.76	10.11	11.51	7.55	8.36	6.47
EPS Growth	3.78%	-12.15%	52.42%	-9.69%	29.21%	8.10%
Dividend Per Share	1.920	1.740	1.320	1.210	0.740	0.740
Dividend Growth	41.18%	31.82%	9.09%	63.51%	-	14.73%
Effective Tax Rate	27.29%	27.54%	25.99%	26.67%	25.07%	25.52%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.